We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
In this episode of ETF Spotlight, I speak with Tim Seymour, founder & CIO of Seymour Asset Management and co-host of CNBC's Fast Money, about broader markets, cannabis investing and the Amplify Seymour Cannabis ETF (CNBS - Free Report) .
Stocks have been on a roller coaster ride since Friday mainly on concerns related to the new variant of the coronavirus and faster taper timeline. Where should investors put their cash to work?
Cannabis stocks & ETFs are down this year, despite favorable policy outlook and improving industry fundamentals. Investors were earlier hopeful for a more rapid path to full federal legalization with the Democratic majority in both chambers of Congress.
These stocks had rallied briefly last month after reports of a Republican-led legislation proposal that aimed to legalize marijuana at the federal level but gave up their gains after investors realized that prospects of passage are rather low as of now. Tim believes that investors should be paying attention to the SAFE Banking Act that is more important for the industry.
Cannabis remains illegal in most countries around the world. The new government in Germany appears to be in favor of legalizing marijuana for recreational use, and it could become the first major European country to do so.
Bloomberg News recently reported that Monster Beverage (MNST - Free Report) is interested in a tie-up with Constellation Brands (STZ - Free Report) , which has a stake of almost 40% in Canopy Growth (CGC - Free Report) .
We have seen a lot of consolidation in the industry lately and Tim expects the trend to continue into 2022. What does all this mean for this fast-growing industry?
CNBS now has exposure to Multi-State Operators (MSOs) via swaps. Top holdings in the actively managed ETF also include Canopy Growth (CGC - Free Report) and Village Farms (VFF - Free Report) .
Tune in to the podcast to learn more.
Make sure to be on the lookout for the next edition of ETF Spotlight and also make sure to subscribe! If you have any comments or questions, please email podcast@zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Should You Buy Beaten Down Cannabis Stocks & ETFs Now?
In this episode of ETF Spotlight, I speak with Tim Seymour, founder & CIO of Seymour Asset Management and co-host of CNBC's Fast Money, about broader markets, cannabis investing and the Amplify Seymour Cannabis ETF (CNBS - Free Report) .
Stocks have been on a roller coaster ride since Friday mainly on concerns related to the new variant of the coronavirus and faster taper timeline. Where should investors put their cash to work?
Cannabis stocks & ETFs are down this year, despite favorable policy outlook and improving industry fundamentals. Investors were earlier hopeful for a more rapid path to full federal legalization with the Democratic majority in both chambers of Congress.
These stocks had rallied briefly last month after reports of a Republican-led legislation proposal that aimed to legalize marijuana at the federal level but gave up their gains after investors realized that prospects of passage are rather low as of now. Tim believes that investors should be paying attention to the SAFE Banking Act that is more important for the industry.
Cannabis remains illegal in most countries around the world. The new government in Germany appears to be in favor of legalizing marijuana for recreational use, and it could become the first major European country to do so.
Bloomberg News recently reported that Monster Beverage (MNST - Free Report) is interested in a tie-up with Constellation Brands (STZ - Free Report) , which has a stake of almost 40% in Canopy Growth (CGC - Free Report) .
We have seen a lot of consolidation in the industry lately and Tim expects the trend to continue into 2022. What does all this mean for this fast-growing industry?
CNBS now has exposure to Multi-State Operators (MSOs) via swaps. Top holdings in the actively managed ETF also include Canopy Growth (CGC - Free Report) and Village Farms (VFF - Free Report) .
Tune in to the podcast to learn more.
Make sure to be on the lookout for the next edition of ETF Spotlight and also make sure to subscribe! If you have any comments or questions, please email podcast@zacks.com.